CClinicalTrials.gg
Sign In
CompletedNCT04110600Updated Oct 1, 2019

Efficacy of Coffee Versus Peppermint Oil Intake in Promoting GIT Motility After Cesarean Section

An interventional study of Coffee effect on early gastric motility and Efficacy pepper mint oil on motility in Gastrointestinal Motility and Defecation Conditions, sponsored by Ain Shams Maternity Hospital. Completed at 1 site in Egypt. Open to female participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-10-01.

Sponsored by Ain Shams Maternity Hospital · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Mar 2019, registered Sep 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
2
Allocation
Randomized
Sex
Female
01

Study summary

It is a comparison between coffee effect versus peppermint oil in promoting GIT motility after cesarean section

Read the detailed description

This study includes 600 patients who underwent cesarean delivery under spinal anaethesia subdivided into two groups each contain 300 patients Group 1 will have 100 ml of coffee after 2,4 and 6 hours Group 2 will have 100 me of pepper mint oil After 2,4 and 6 hours

Then outcomes will be assessed as per time frame

02

Conditions studied

  • Gastrointestinal Motility and Defecation Conditions

Keywords

  • Bowel movements
  • Cesarean section
  • Oral hydration
03

In context

Lead sponsor

Ain Shams Maternity Hospital is the lead sponsor of 135 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • willingness to participate.
  • uncomplicated pregnancy.
  • uncomplicated cesarean section.
  • under regional anesthesia
  • BMI\<30kg/m.
  • level of hemoglobin is 10g/dl or more

Exclusion criteria

Exclusion Criteria:

  • medical disorders in the form of HTN,DM and hepatic disorders and bleeding disorders
  • intra operative bowel or bladder injury during the cesarean section
  • intra operative severe bleeding
  • chronic gastrointestinal problems like chronic constipation ,peptic ulcer ,esophagitis ,hiatus hernia and IBS
  • sever intestinal adhesions
  • Respiratory problems and infection that require medication intervention
  • operation more than 90 minutes
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
2 participants (actual)

Study arms

  • Active comparator
    Coffee group

    This group includes 300 patients who underwent cesarean delivery under spinal anaesthesia And will have 100 ml of coffee after 2,4 and 6 hours Then outcomes will be assessed as per time frame

    Other: Coffee effect on early gastric motility

  • Active comparator
    Pepper mint oil group

    This group includes 300 patients who underwent cesarean delivery under spinal anaesthesia This group will have 100 ml of pepper mint oil After 2,4 and 6 hours Then outcomes will be assessed as per time frame

    Other: Efficacy pepper mint oil on motility

Interventions

  • OtherCoffee effect on early gastric motility

    this group 100ml coffee after two hours

    Also known as: Coffee intake

  • OtherEfficacy pepper mint oil on motility

    This group 100me pepper mint oil after 2 hours

    Also known as: Pepper mint oil

06

What researchers measure

Primary outcomes

  1. Regain of GIT motility after cesarean section by auscultation of intestinal sound

    Auscultation of intestinal sounds hourly for first 12. Hours

    Time frame: First 12 hours after cs

Secondary outcomes

  1. Sense of nausea

    Nausea sensation

    Time frame: First 24 hours after cs

  2. Sense of vomiting

    Recording time for first time of vomiting

    Time frame: First 24 hours after cs

  3. First passage of flatus

    Record first passage of flatus

    Time frame: First 24 hours after cs

  4. First defection

    Record first bowel motjon

    Time frame: First 24 hours after cs

  5. Effect on abdominal distention

    Recording incidence of distension

    Time frame: First 24 hours after cs

  6. Need of medication to enhance motility of GIT

    Assessing need for extra medications for motility

    Time frame: First 24 hours after cs

  7. Length of hospital stay after surgery

    Recording length of stay

    Time frame: First 24 hours after cs

07

Study locations

1 site
  • Ain shams maternity hospital
    Cairo, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 1, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04110600
Lead sponsor
Ain Shams Maternity Hospital
Responsible party
amaal ehab mostafa (obstetrics and gynaecology resident, Ain Shams Maternity Hospital) — Principal investigator
First posted
Oct 1, 2019
Start date
Mar 1, 2019
Primary completion
Sep 20, 2019
Completion
Sep 20, 2019
Last update
Oct 1, 2019

Study contacts

Nermine Elghareb, Lecturer
study director · Ain Shams Maternity Hospital
Ahmed Tharwat, Professor
study director · Ain Shams Maternity Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Ain Shams Maternity Hospital

Start the discussion